19 of 20 of the top Life Sciences companies use OpenText solutions
Life Sciences information is often disconnected and stored separately from the processes and transactions it was created to support. This siloed information hinders insights, hurting innovation and efficiency. To accelerate life-saving therapies development, companies need to harmonize and integrate systems and applications to unlock their information’s full potential.
As patients evolve into healthcare consumers, expecting better and improved health, Life Sciences companies are becoming more patient-centric.
The pandemic has increased trial activities conducted remotely and in participants’ homes, furthering the shift from centralized to decentralized clinical trials.
The need for efficiency continues to drive the industry with half of new Life Sciences businesses expecting to move to cloud-based ecosystems by 2026.
Product development timelines are accelerated by advances in personalized medicine and unmet needs, requiring improved knowledge transfer among healthcare collaborators.
With growing amounts of intellectual property and public health data, ransomware attacks on Life Sciences companies are rising, with a 50% jump from 2019 to 2020 alone.
To ensure supply chain flexibility and resilience and avoid demand disruptions, Life Sciences companies are looking to integration solutions with end-to-end visibility.